Pharmaceuticals France

France GERD Treatment Market Analysis, 2024–2034

France GERD Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

France · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $181.1 Mn Estimated value
Estimate 2025 $186.4 Mn 2.5% of the global market
Projected 2034 $241.0 Mn 29.3% Adds $54.7 Mn over 9 forecast years
CAGR 2025–2034 2.9% Faster than 6% of 180 Pharmaceuticals markets here
Key players 5
  • France is 2.46% of the global market.
  • In Europe, the largest is Germany at $295.5 Mn.
  • Fastest growing: Russia at 3.9% a year.
  • France ranks 4th of 6 by size in Europe.

Market size projection

France

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$54.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
GERD Treatment Market market size by year, France
YearMarket sizeChange that yearSince 2025
2024 (estimate) $181.1 Mn — —
2025 (base) $186.4 Mn +$5.3 Mn —
2026 (forecast) $191.8 Mn +$5.4 Mn +2.9%
2027 (forecast) $197.3 Mn +$5.6 Mn +5.9%
2028 (forecast) $203.0 Mn +$5.7 Mn +9%
2029 (forecast) $208.9 Mn +$5.9 Mn +12.1%
2030 (forecast) $215.0 Mn +$6.1 Mn +15.4%
2031 (forecast) $221.2 Mn +$6.2 Mn +18.7%
2032 (forecast) $227.6 Mn +$6.4 Mn +22.2%
2033 (forecast) $234.2 Mn +$6.6 Mn +25.7%
2034 (forecast) $241.0 Mn +$6.8 Mn +29.3%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $7.57 Bn
  2. North America $3.71 Bn
  3. US $3.29 Bn
  4. APAC $1.75 Bn
  5. Europe $1.58 Bn
  6. Canada $679.0 Mn
  7. China $676.3 Mn
  8. Japan $419.4 Mn
  9. Middle East $354.2 Mn
  10. Latin America $318.2 Mn
  11. Germany $295.5 Mn
  12. UK $208.8 Mn
  13. Italy $190.8 Mn
  14. France (this report) $186.4 Mn
  15. Brazil $188.0 Mn
  16. Spain $156.1 Mn
  17. Ecuador $158.8 Mn
  18. India $138.3 Mn
  19. Africa $123.7 Mn
  20. Saudi Arabia $118.1 Mn
  21. Mexico $103.1 Mn
  22. Australia $103.3 Mn
  23. New Zealand $86.5 Mn
  24. Russia $70.5 Mn
  25. South Africa $49.3 Mn
  26. UAE $40.7 Mn
  27. Egypt $23.0 Mn
  28. Philippines $16.3 Mn
  29. Hong Kong $13.4 Mn
  30. Malaysia $12.5 Mn
  31. Thailand $10.3 Mn
  32. Singapore $9.8 Mn
  33. Kenya $4.6 Mn

The France GERD Treatment Market Analysis Executive Summary

GERD treatments relieve acid reflux and heartburn with acid-lowering medicines and procedures.

Key segments of the GERD Treatment market include treatment (Proton Pump Inhibitors, P-CABs and H2 Blockers) and channel (Prescription and Over-the-Counter).

France GERD Treatment Market Dynamics

Market Growth Drivers

Rising rates of gut and liver disease linked to diet, obesity and alcohol, more screening and new treatments are driving the GERD Treatment market.

Opportunity

Microbiome-based treatments, earlier testing and digital gut-health programmes give the GERD Treatment market room to grow.

Market Restraints

Late diagnosis, stigma, limited specialist access and high prices of new medicines hold back the GERD Treatment market.

Competitive Landscape for GERD Treatment Market in France

The GERD Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for GERD Treatment Market in France

GERD Treatment in France: rules, payment and research

Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by ANSM, the French medicines agency.⁠[1] National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover.⁠[2] ClinicalTrials.gov lists 9 studies on GERD Treatment that are recruiting, active or about to start in France.⁠[3]

[1] ANSM, French medicines agency. Checked 14 Nov 2026.

[2] Assurance Maladie (ameli.fr). Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in France. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for GERD Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in France.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in GERD Treatment right now, from free public sources.

Clinical trials

9 active trials in France

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. HK inno.N Corporation 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Polares Medical SA 3 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Implantica CE Reflux Ltd. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Cellmedis 2 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Onconic Therapeutics Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 82 papers since 2021 (worldwide)

  1. Comparison of the Efficacy of Dexrabeprazole and Rabeprazole in Inhibiting Intragastric and Intraesophageal Acidity in Gastroesophageal Reflux Disease. Journal of clinical gastroenterology, 2026
  2. Transoral Endoscopic Clip Band Ligation Anti-reflux Therapy (C-BLART) for Gastroesophageal Reflux Disease: A Retrospective Analysis of Efficacy and Safety in 37 Patients. Digestive diseases and sciences, 2026
  3. Efficacy and safety of potassium-competitive acid blockers in eradicating Helicobacter pylori and treating gastro-esophageal reflux disease: A systematic review and meta-analysis. Caspian journal of internal medicine, 2026
  4. Conversion to One-Anastomosis Gastric Bypass versus Roux-en-Y Gastric Bypass for Treatment of Gastroesophageal Reflux Disease after Sleeve Gastrectomy: A Systematic Review and Meta-analysis. Obesity surgery, 2026
  5. Cost-effectiveness of RefluxStop for gastroesophageal reflux disease: analysis from an Italian healthcare perspective. BMC gastroenterology, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

GERD Treatment in context

France compared

  • Health spending per person: 5,327 US$ per person (2024). World: 1,317 US$ per person (2023). 3rd highest of the 6 countries we cover in Europe.[1]
  • Doctors: 3.28 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 6th highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 22.5% of people (2025). World: 10.4% of people (2025). 3rd highest of the 6 countries we cover in Europe.[3]

Questions, answered with public data

How many clinical trials on GERD Treatment are running in France?
9 studies are recruiting, active or about to start in France.[4]
How much research is published on GERD Treatment?
PubMed lists 82 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in France. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about GERD Treatment in France? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Prebiotics: Feeding the Good BacteriaMore than 90% of US women and 97% of men do not eat enough fibre. Prebiotics are the fibres that feed helpful… Gut Health and Probiotics: What the Science SaysGut health is one of the biggest wellness trends. Probiotics help in some cases, but not all products or… Acid Reflux (GERD): Common, Costly and TreatableUp to 20% of people in the US have GERD, and it led to 26.7 million US clinic visits in 2015. Most cases can…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in France

See all
Same topic, other categories

Related on gut health

See the topic